Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ga68-PSMA-11 PET Imaging in Prostate Cancer Undergoing ADT
NCT03977610Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jun 2019
- Primary completion
- Jul 2021
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
Open-label, single-arm trial of gallium ga-68 gozetotide in prostate cancer (PCa), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Change of lesion detection number by PET imaging. Started Jun 2019; status: completed.
02
Drugs
gallium ga-68 gozetotide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03977610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03977610.